Editorial-Details (JVRAV)
Vipin Kumar Yadav
Malignant Hematology Department
H. Lee Moffitt Cancer Center & Research Institute
USA
Biography
Dr. Vipin Kumar Yadav is a Postdoctoral Researcher in Malignant Hematology at the H. Lee Moffitt Cancer Center and Research Institute, USA. He earned his M.S. in Applied Microbiology from Banaras Hindu University and his Ph.D. in Biological Science from the CSIR-Indian Institute of Toxicology Research, India. His research focuses on the molecular mechanisms underlying hematologic malignancies, particularly myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia. His work integrates molecular biology, genomics, transcriptomics, proteomics, and functional genomics to identify novel therapeutic targets and overcome treatment resistance. He has also made significant contributions to cancer biology through studies on autophagy, post-translational modifications, melanoma biology, UV-induced DNA damage, and immunogenic cell death. Dr. Yadav has authored numerous peer-reviewed publications in leading international journals and is actively involved in translational cancer research aimed at developing mechanism-based therapies for hematologic and solid malignancies.
Research Interest
Hematologic Malignancies, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia, Molecular Hematology, Cancer Biology, Translational Oncology, Long Noncoding RNAs, MALAT1 Biology, Gene Regulation, Transcriptional Regulation, Epigenetics, Post-Translational Modifications, Protein Nitrosylation, Autophagy, Immunogenic Cell Death, Cancer Immunology, Melanoma Research, Tumor Microenvironment, Functional Genomics, Genomics, Transcriptomics, Proteomics, Molecular Therapeutics, Drug Resistance, Precision Oncology, Biomarker Discovery, RNA Biology, Molecular Diagnostics, Targeted Cancer Therapy.

